DrugPatentWatch Database Preview

Norway Supplementary Protection Certificates

« Back to Dashboard

Supplementary Protection Certificates

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	2182988	2015006	Norway	PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822
European Patent Office	2203462	2014029	Norway	PRODUCT NAME: SOFOSBUVIR. (S)-ISOPROPYL 2-; NAT. REG. NO/DATE: EU/1/13/894 20140116; FIRST REG. NO/DATE: (001-002) 20140117
European Patent Office	2368890	2015012	Norway	PRODUCT NAME: OMBITASVIR, ELLER ET; REG. NO/DATE: EU/1/14/982 20150120
European Patent Office	2310095	2017004	Norway	PRODUCT NAME: GRAZOPREVIR ELLER ET; REG. NO/DATE: EU/1/16/1119 20160804
European Patent Office	2430014	2016004	Norway	PRODUCT NAME: LEDIPASVIR; REG. NO/DATE: EU/1/14/958 20141203
European Patent Office	2498802	2017030	Norway	PRODUCT NAME: INSULIN GLARGINE/LIXISENATIDE; REG. NO/DATE: EU/1/16/1157 20170125